Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine

Shathiyah Kulandavelu, Vasileios Karantalis, Julia Fritsch, Konstantinos E. Hatzistergos, Viky Y. Loescher, Frederic McCall, Bo Wang, Luiza Bagno, Samuel Golpanian, Ariel Wolf, Justin Grenet, Adam Williams, Aaron Kupin, Aaron Rosenfeld, Sadia Mohsin, Mark A. Sussman, Azorides Morales, Wayne Balkan, Joshua M. Hare

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Background Pim1 kinase plays an important role in cell division, survival, and commitment of precursor cells towards a myocardial lineage, and overexpression of Pim1 in ckit+ cardiac stem cells (CSCs) enhances their cardioreparative properties. Objectives The authors sought to validate the effect of Pim1-modified CSCs in a translationally relevant large animal preclinical model of myocardial infarction (MI). Methods Human cardiac stem cells (hCSCs, n = 10), hckit+ CSCs overexpressing Pim1 (Pim1+; n = 9), or placebo (n = 10) were delivered by intramyocardial injection to immunosuppressed Yorkshire swine (n = 29) 2 weeks after MI. Cardiac magnetic resonance and pressure volume loops were obtained before and after cell administration. Results Whereas both hCSCs reduced MI size compared to placebo, Pim1+ cells produced a ∼3-fold greater decrease in scar mass at 8 weeks post-injection compared to hCSCs (−29.2 ± 2.7% vs. −8.4 ± 0.7%; p < 0.003). Pim1+ hCSCs also produced a 2-fold increase of viable mass compared to hCSCs at 8 weeks (113.7 ± 7.2% vs. 65.6 ± 6.8%; p <0.003), and a greater increase in regional contractility in both infarct and border zones (both p < 0.05). Both CSC types significantly increased ejection fraction at 4 weeks but this was only sustained in the Pim1+ group at 8 weeks compared to placebo. Both hCSC and Pim1+ hCSC treatment reduced afterload (p = 0.02 and p = 0.004, respectively). Mechanoenergetic recoupling was significantly greater in the Pim1+ hCSC group (p = 0.005). Conclusions Pim1 overexpression enhanced the effect of intramyocardial delivery of CSCs to infarcted porcine hearts. These findings provide a rationale for genetic modification of stem cells and consequent translation to clinical trials.

Original languageEnglish (US)
Pages (from-to)2454-2464
Number of pages11
JournalJournal of the American College of Cardiology
Volume68
Issue number22
DOIs
StatePublished - Dec 6 2016

Keywords

  • heart failure
  • human cardiac progenitor cells
  • injection
  • pressure volume

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pim1 Kinase Overexpression Enhances ckit<sup>+</sup> Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine'. Together they form a unique fingerprint.

  • Cite this

    Kulandavelu, S., Karantalis, V., Fritsch, J., Hatzistergos, K. E., Loescher, V. Y., McCall, F., Wang, B., Bagno, L., Golpanian, S., Wolf, A., Grenet, J., Williams, A., Kupin, A., Rosenfeld, A., Mohsin, S., Sussman, M. A., Morales, A., Balkan, W., & Hare, J. M. (2016). Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine. Journal of the American College of Cardiology, 68(22), 2454-2464. https://doi.org/10.1016/j.jacc.2016.09.925